INFERNOWEIGHTLOSS.COM REFERENCES

During our research we credit the following references:

1: Oswal A, Yeo G 2010, 'Leptin and the control of body weight: a review of its diverse central targets, signalling mechanisms, and role in the pathogenesis of obesity', Obesity (Silver Spring), vol. 18, no. 2, pp. 221–229.

2: Gallagher EJ, Leroith D, Karnieli E 2010, 'Insulin resistance in obesity as the underlying cause for the metabolic syndrome', Mt Sinai Journal of Medicine, vol. 77, no. 5, pp. 511–523.

3: Lovejoy JC, Sainsbury A 2008, 'Sex differences in obesity and the regulation of energy homeostasis', Obesity Review, vol. 10, no. 2, pp. 154–167.

4: Rasmussen MH 2010, 'Obesity, growth hormone and weight loss', Molecular and Cell Endocrinology, vol. 316, no. 2, pp. 147–153.

5: Pi-Sunyer X 2009, ‘The medical risks of obesity’, Postgraduate Medicine, vol. 121, no. 6, pp. 21–33.

6: Frank GK, Oberndorfer TA, Simmons AN, et al. Sucrose activates human taste pathways differently from artificial sweetener. Neuroimage. 2008;39:1559-69.

7: Barnaba V., Paroli M., Piconese S. (2012). The ambiguity in immunology. Front. Immun. 3:1810.3389/fimmu.2012.00018

8: Chilton P. M., Embry C. A., Mitchell T. C. (2012). Effects of differences in lipid A structure on TLR4 pro-inflammatory signaling and inflammasome activation. Front. Immun. 3:15410.3389/fimmu.2012.00154

9: Fujio K., Okamura T., Sumitomo S., Yamamoto K. (2012). Regulatory T cell-mediated control of autoantibody-induced inflammation. Front. Immun. 3:28 10.3389/fimmu.2012.00028 

10: Mauro C., Marelli-Berg F. M. (2012). T cell immunity and cardiovascular metabolic disorders: does metabolism fuel inflammation? Front. Immun. 3:173 10.3389/fimmu.2012.00173

11: US Department of Agriculture, Department of Communications, Agriculture Fact Book, 2001-2002, http://www.usda.gov/factbook/chapter2.pdf

12: American Cancer Society. Cancer Facts and Figures—1997. Atlanta, GA: 1999.

13: Donegan WL, Hartz AJ, Rimm AA. The association of body weight with recurrent cancer of the breast. Cancer. 1978;41:1590-1594.

14: Robert H. Lustig, MD, professor of pediatrics, University of California, San Francisco;  member, Endocrine Society's Obesity Task Force.